Cargando…

Epidemiology and Microbiology of First Ventricular Assist Device Infection and Their Effect on Outcomes

BACKGROUND: Left ventricular assist devices (VADs) are life-saving for patients with end stage heart failure but their benefits are limited due to infectious complications. Large studies looking at the site of infection and microbiology on outcomes are not available. METHODS: We conducted a single c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guzman, Merilda Blanco, Vader, Justin, Olsen, Margaret, Dubberke, Erik R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630853/ http://dx.doi.org/10.1093/ofid/ofx163.1738

Ejemplares similares

2152. Epidemiology and Clinical Outcomes of Contemporary, Third-Generation Left Ventricular Assist Device (LVAD) Infections
por: Hershberger, Todd E, et al.
Publicado: (2018)

Re‐Thinking Re‐Synching in Left Ventricular Assist Device Recipients
por: Vader, Justin M., et al.
Publicado: (2018)

2693. Epidemiology of Infections with Multidrug-Resistant Organisms in Patients with Left Ventricular Assist Devices (LVADs)
por: Axell-House, Dierdre B, et al.
Publicado: (2023)

737. Timing, Microbiology, Antibiotic Use, and Financial Impact of Left Ventricular Assist Device Infections: A Prospective Case-Control Approach
por: Ficinski, Matthew, et al.
Publicado: (2023)

113 Procedure-specific Surgical Site Infection (SSI) Prevalence Widely Varies within Certain NHSN (National Healthcare Safety Network) Surgery Groups
por: Saeed, Mohammed, et al.
Publicado: (2014)

2883. Comparative outcomes following Candida bloodstream infections in patients with left ventricular assist devices (LVAD)
por: Mansoor, Armaghan-e-Rehman, et al.
Publicado: (2023)

584. Ventricular assist device infections with Pseudomonas aeruginosa
por: Roberts, Scott C, et al.
Publicado: (2020)

2765. Dalbavancin for challenging left ventricular assist device driveline infections
por: Doligalski, Christina, et al.
Publicado: (2023)

2625. Characteristics and Outcomes of COVID-19 in Patients with a Left Ventricular Assist Device
por: Fleites, Jorge, et al.
Publicado: (2023)

704. Evaluation of Risk Factors and Outcomes of Early Left Ventricular Assist Device Infections
por: Shealy, Stephanie, et al.
Publicado: (2020)

752. Costs Attributable to Clostridioides difficile Infection in the Presence of Differential Mortality
por: Sahrmann, John, et al.
Publicado: (2021)

127. Novel Treatment Approach for Left Ventricular Assist Device-related Infections
por: Yalcin, Yunus C, et al.
Publicado: (2019)

2021. Efficacy of Chronic Antimicrobial Suppressive Therapy in Ventricular Assist Device Infections
por: Teran, Nicholas S, et al.
Publicado: (2022)

1319. Microbiology and Epidemiology of Pediatric Ventriculoperitoneal Shunt Infections
por: Claunch, Kevin M, et al.
Publicado: (2023)

Abstract: Outcomes of Flap Coverage of Infected and Exposed Cardiac Ventricular Assist Devices
por: Dawlagala, Nadeera, et al.
Publicado: (2017)

Epidemiology, Microbiology and Outcomes of Catheter-Associated Urinary Tract Infection and Complicated Urinary Tract Infection in the USA
por: Merchant, Sanjay, et al.
Publicado: (2017)

Three-year outcomes with left ventricular assist devices in country with restricted heart transplantation
por: Medressova, Assel, et al.
Publicado: (2015)

94. Infectious Complications of Left Ventricular Assist Devices
por: Harris, Courtney, et al.
Publicado: (2021)

712 Gram-negative associated Ventricular Assist Device infections
por: Patel, Ami, et al.
Publicado: (2014)

1180. Colonization with Multidrug-Resistant Organisms Is Associated with Subsequent Infection in the Ventricular Assist Device Population
por: Roberts, Scott C, et al.
Publicado: (2019)

1540. Left Ventricular Assist Device Driveline Infections: Relapsed Infections and Minimum Inhibitory Concentration Changes
por: Lines, Tara, et al.
Publicado: (2018)

Complications in defibrillator surgery in patients with implanted ventricular assist device
por: Schroeter, Thomas, et al.
Publicado: (2015)

2427. Characterization of Early Healthcare-Associated Infections (HAI) After Implantation of Left Ventricular Assist Devices (LVAD)
por: Kling, Kendall, et al.
Publicado: (2023)

902. Selection of Antibiotics for Prophylaxis of Left Ventricular Assist Device Surgical Infections: More is Not More
por: Nguyen, Peter T, et al.
Publicado: (2020)

683. Epidemiology and Microbiology of Infective Endocarditis: A Six Year Experience
por: Muhammed, Niyas Vettakkara Kandy, et al.
Publicado: (2021)

U.S. Combat-related Invasive Fungal Wound Infection (IFI) Epidemiology and Wound Microbiology: Afghanistan Theater 2009–2014
por: Ganesan, Anuradha, et al.
Publicado: (2017)

Electronic and Microbiological Detection, Investigation, and Surveillance for Potential Hospital- Acquired Device Associated Infections at ERCP.
por: Ross, Jack
Publicado: (2017)

1176. Antibiotic Prophylaxis Strategies Prior to Left Ventricular Assist Device Implantation: A Survey of Practice
por: Mourad, Ahmad, et al.
Publicado: (2019)

2763. Evaluating the Safety and Effectiveness of Long-term Antibiotic Suppression in Patients with Left Ventricular Assist Devices
por: Hamlin, Kelsey D, et al.
Publicado: (2023)

Outcomes of Hospitalizations for Cardiogenic Shock at Left Ventricular Assist Device Versus Non–Left Ventricular Assist Device Centers
por: Wang, Joseph I., et al.
Publicado: (2020)

Pharmacokinetic Assessment of Continuous Infusion Ceftolozane/Tazobactam for Drug-Resistant Pseudomonas aeruginosa Left Ventricular Assist Device Driveline Infection
por: Foster, Rachel, et al.
Publicado: (2017)

1587. Analysis of Breakthrough Blood Stream Infections in Left Ventricular Assist Device Recipients Managed With Chronic Antimicrobial Suppressive Therapy
por: Jandhyala, Deeksha, et al.
Publicado: (2018)

Ventricular Assist Device-Specific Infections
por: Qu, Yue, et al.
Publicado: (2021)

1014. Microbiology and Outcome of Bloodstream Infections in Children With Intestinal Failure
por: Seddik, Talal, et al.
Publicado: (2018)

No Association between Clinical Periodontal Conditions and Microbiological Findings on Driveline of Patients with Left-Ventricular Assist Devices (LVAD)
por: Schmalz, Gerhard, et al.
Publicado: (2021)

1474. Epidemiology and Outcomes of Hospitalized Patients with Urinary Tract Infections (UTI) Due to Multidrug-Resistant Organisms (MDRO)
por: Lahrman, Frances J, et al.
Publicado: (2019)

Association of pre–left ventricular assist device defibrillator shocks for ventricular arrhythmia with clinical outcomes after left ventricular assist device implantation
por: Wann, Daniel G., et al.
Publicado: (2023)

Microbiological Epidemiology in Patients Experiencing Microbiological or Clinical Failure Following Reimplantation After a Two-Stage Exchange Strategy for Hip or Knee Prosthetic Joint Infection (PJI)
por: Ferry, Tristan, et al.
Publicado: (2017)

238. Comparison of Outcomes of Patients with Gram-Negative Bacterial Left Ventricular Assist Device-Related Infections on Chronic Suppressive Antibiotic Therapy versus Patients Monitored on No Antibiotic Therapy
por: Svoronos, Petros, et al.
Publicado: (2023)

The Impact of Obesity on Left Ventricular Assist Device Outcomes
por: Zhigalov, Konstantin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_uodd6upbidc882kcqvspm0j8r1